Transtek(SZ:300562) Sou Hu Cai Jing·2025-07-09 09:29Company Overview - LeXin Medical focuses on health IoT and digital health services, offering products such as smart electronic blood pressure monitors, health scales, blood glucose monitoring devices, fat measuring instruments, ECG monitoring equipment, smart bands, and smartwatches [2] - The company is recognized as a national high-tech enterprise and has established several research and development centers, including the Guangdong Provincial Engineering Technology Research Center [2] - LeXin Medical has obtained various international certifications, including ISO13485:2016, ISO9001:2015, ISO14001:2015, FDA registration, CE certification, and others, indicating its commitment to quality and international standards [2] Financial Performance - In the first quarter of 2025, LeXin Medical reported revenue of 273 million yuan, representing a year-on-year increase of 9.90%, and a net profit of 22.94 million yuan, up 67.88% year-on-year, with a gross profit margin of 37.38% [2] - As of July 9, 2023, the company's stock closed at 15.85 yuan, with a rolling PE ratio of 48.79, marking a new low in 65 days, and a total market capitalization of 3.447 billion yuan [1] Industry Comparison - The average PE ratio for the medical device industry is 51.36, with a median of 37.22, placing LeXin Medical at the 87th position within the industry [1][3] - The company's current PE ratio is lower than the industry average, indicating potential valuation opportunities [1][3]